Alzheimer’s disease expert Dr. Robert Alexander will help shape the future development path of T3D Therapeutics’ lead drug candidate T3D-959 as a potential disease remedial therapy for Alzheimer’s patients. RESEARCH TRIANGLE PARK, N.C., July 25, 2024 /PRNewswire/ — T3D Therapeutics,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.